Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

tagraxofusp

(tag-RAK-soh-fusp)
A drug used to treat adults and children aged 2 years and older with a rare blood cancer called blastic plasmacytoid dendritic cell neoplasm. It is also being studied in the treatment of other types of cancer. Tagraxofusp is made up of interleukin-3 (IL-3), which binds to an IL-3 receptor protein called CD123. CD123 may be found in higher than normal amounts on some types of cancer cells. Tagraxofusp is also made up of a diphtheria toxin, which may help kill cancer cells. Tagraxofusp is a type of cytotoxin. Also called Elzonris.
Search NCI's Dictionary of Cancer Terms